Table 1.

Selected characteristics of patients with (cases) and without (controls) incident sporadic colorectal adenoma, MAP II

Characteristic*Cases (n = 31)Controls (n = 29)P
Age (y)55.0 ± 1.454.7 ± 1.50.89
Male (%)41.944.81.00
Caucasian (%)93.596.61.00
Current smoker (%)16.110.30.14
College graduate (%)35.527.60.83
HRT use among women (%)87.566.70.22
Consumes alcohol currently (%)64.565.51.00
Regular NSAID use (%)32.355.20.12
Regular aspirin use (%)32.337.90.79
1st degree relative with CRC (%)10.025.90.17
Recreational physical activity (METs/d)27.9 ± 3.521.6 ± 3.60.22
Body mass index (kg/m2)30.5 ± 1.432.3 ± 1.40.37
Daily intakes
    Total energy intake (kcal)1,943.8 ± 121.31,624.3 ± 125.50.07
    Total fiber intake (g)14.1 ± 4.915.3 ± 6.60.42
    Total calcium intake (mg)928.8 ± 85.3867.9 ± 88.30.63
    Total vitamin D intake (IU)335.7 ± 52.1321.0 ± 54.00.85
    Total folate intake (μg)471.9 ± 45.8491.0 ± 47.40.78
    Sucrose intake (g)40.3 ± 2.935.8 ± 3.00.30
    Whole fruit and vegetable servings/d3.3 ± 0.303.4 ± 0.310.57
Weekly intakes
    Processed meat servings/wk2.2 ± 0.302.6 ± 0.370.37
    Red meat servings/wk6.2 ± 2.58.2 ± 2.50.58
    Low-fat dairy servings/wk4.5 ± 1.04.1 ± 1.00.79
  • Abbreviations: HRT, hormone replacement therapy; CRC, colorectal cancer; MET, metabolic equivalents.

  • * Mean ± SE presented unless otherwise specified.

  • Fisher's exact for categorical variables; Pdiff (ANCOVA) for continuous variables; adjusted for age and total energy intake as appropriate.

  • Total intake (diet + supplements) adjusted for total energy intake.